TD Asset Management
RGNX icon

TD Asset Management’s Regenxbio RGNX Stock Holding History

TD Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,441
Closed -$305K – 1458
2022
Q4 		$305K Hold
13,441
– – ﹤0.01% 1356
2022
Q3 		$335K Hold
13,441
– – ﹤0.01% 1357
2022
Q2 		$332K Sell
13,441
-7,159
-35% -$179K ﹤0.01% 1345
2022
Q1 		$684K Hold
20,600
– – ﹤0.01% 1302
2021
Q4 		$674K Hold
20,600
– – ﹤0.01% 1348
2021
Q3 		$864K Buy
20,600
+435
+2% +$15.7K ﹤0.01% 1287
2021
Q2 		$652K Hold
20,165
– – ﹤0.01% 1354
2021
Q1 		$688K Buy
20,165
+1,645
+9% +$70.2K ﹤0.01% 1340
2020
Q4 		$840K Hold
18,520
– – ﹤0.01% 1221
2020
Q3 		$510K Hold
18,520
– – ﹤0.01% 1235
2020
Q2 		$682K Hold
18,520
– – ﹤0.01% 1152
2020
Q1 		$600K Sell
18,520
-4,700
-20% -$196K ﹤0.01% 1129
2019
Q4 		$951K Sell
23,220
-3,000
-11% -$119K ﹤0.01% 1107
2019
Q3 		$933K Sell
26,220
-7,600
-22% -$308K ﹤0.01% 1069
2019
Q2 		$1.74M Sell
33,820
-1,500
-4% -$74.9K ﹤0.01% 938
2019
Q1 		$2.02M Buy
35,320
+13,900
+65% +$689K ﹤0.01% 900
2018
Q4 		$899K Buy
21,420
+5,220
+32% +$306K ﹤0.01% 1083
2018
Q3 		$1.22M Buy
16,200
+2,600
+19% +$187K ﹤0.01% 1116
2018
Q2 		$976K Buy
13,600
+2,700
+25% +$129K ﹤0.01% 1134
2018
Q1 		$325K Buy
10,900
+200
+2% +$5.82K ﹤0.01% 1269
2017
Q4 		$356K Buy
+10,700
New +$322K ﹤0.01% 1241
2017
Q1 		– Sell
-17,866
Closed -$331K – 1416
2016
Q4 		$331K Sell
17,866
-4,899
-22% -$93.6K ﹤0.01% 1280
2016
Q3 		$319K Sell
22,765
-400
-2% -$4.41K ﹤0.01% 1286
2016
Q2 		$185K Hold
23,165
– – ﹤0.01% 1333
2016
Q1 		$250K Buy
+23,165
New +$296K ﹤0.01% 1272

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TD Asset Management's RGNX Position: Q1 2023 in Review

TD Asset Management sold out of Regenxbio (RGNX) in Q1 2023, closing a stake of 13,441 shares — an estimated $305K sold.

TD Asset Management first reported a position in RGNX in Q1 2016 and held it in 25 quarters. The position peaked at $2.02M in Q1 2019. 174 funds tracked by Wall St. Rank hold RGNX as of Q1 2023.

  • TD Asset Management reported no remaining Regenxbio position as of Q1 2023 after selling out during the quarter.
  • TD Asset Management sold 13,441 Regenxbio shares in Q1 2023, an estimated $305K.
  • TD Asset Management first reported a position in Regenxbio in Q1 2016 and held it in 25 quarters.
  • TD Asset Management's Regenxbio position peaked at $2.02M in Q1 2019.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q1 2023.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.